Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
The Core Decision First Before the hour-by-hour plan, one thing must be settled in your own mind, because everything else flows from it: you disclose, and you disclose fast. Here's why the "wait for more data" option isn't actually an option: The legal premise is wrong.Read the full answer
48-Hour Action Plan: Patient Safety First Critical Reality Check First Your legal team's "6 months" likely refers to a full label revision, not initial safety signal reporting. FDA requires serious unexpected adverse events reported within 15 days (7 days if fatal).Read the full answer